Clinical efficacy of upper limb robotic therapy in people with tetraplegia: a pilot randomized controlled trial.
Junsik Kim, Bum Suk Lee, Hye-Jin Lee...
https://pubmed.ncbi.nlm.nih.gov/30206423/Actively Recruiting
Led by Swiss Paraplegic Research, Nottwil · Updated on 2026-07-08
40
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to compare the effects of robot-assisted therapy using the ArmeoSpring device with conventional occupational therapy on upper limb function in individuals with cervical spinal cord injury cSCI. It focuses on determining which therapy better improves arm and hand function during the intermediate phase of injury, between 2 weeks and 6 months post-injury. The study is designed as a cross-over trial where participants receive both therapies in random order to assess their effectiveness. Participants undergo two consecutive 6-week therapy periods. One period involves unilateral robot-assisted therapy using the ArmeoSpring, an arm orthosis providing adjustable antigravity support with a spring system, delivered 3 times per week for 30 minutes each session. The other period involves unilateral conventional occupational therapy consisting of strengthening, grasping, fine motor, and activity-based tasks with the same frequency and duration. The order of therapies is randomly assigned, with assessments conducted before, between, and after the therapy periods. Throughout the study, participants complete baseline, intermediate, post, and follow-up assessments measuring grasp performance, upper limb function quality, independence in daily activities, motor scores, hand strength, arm control, therapy intensity, and motivation. The follow-up assessment occurs if the post-assessment was done before 150 days post-injury. This allows researchers to monitor changes over time and compare the impact of each therapy on upper limb recovery and daily functioning.
CONDITIONS
Robot-assisted vs. Conventional Occupational Therapy of the Upper Limb in Individuals With Cervical Spinal Cord Injury
M
Mario Widmer, Dr. sc. ETH
C
Chantal Wunderlin
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Swiss Paraplegic Research, Nottwil
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 weeks
Participants randomly receive one therapy first: either unilateral robot-assisted therapy using the ArmeoSpring or conventional occupational therapy for the upper limb. Each therapy lasts 6 weeks, with sessions three times per week for 30 minutes each.
3 sessions per week
Duration - 6 weeks
After completing the first therapy, participants switch to the other therapy for another 6 weeks under the same schedule of three 30-minute sessions per week.
3 sessions per week
Duration - Up to 18 weeks
Participants complete baseline, intermediate, post, and follow-up assessments measuring upper limb function, grasp performance, independence in daily activities, motor scores, hand strength, arm control, motivation, and therapy intensity.
Assessments at weeks 1, 7, 14, and 18
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Junsik Kim, Bum Suk Lee, Hye-Jin Lee...
https://pubmed.ncbi.nlm.nih.gov/30206423/Hardeep Singh, Janelle Unger, José Zariffa...
https://pubmed.ncbi.nlm.nih.gov/29334467/Nuray Yozbatiran, Gerard E Francisco
https://pubmed.ncbi.nlm.nih.gov/30954153/Joo Hwan Jung, Hye Jin Lee, Duk Youn Cho...
https://pubmed.ncbi.nlm.nih.gov/31499598/Daniela B Kuchen, Beatrice Hubacher, Andris Ladner...
https://pubmed.ncbi.nlm.nih.gov/38063623/G J Snoek, M J IJzerman, H J Hermens...
https://pubmed.ncbi.nlm.nih.gov/15224087/Kim D Anderson
https://pubmed.ncbi.nlm.nih.gov/15672628/James V Lynskey, Adam Belanger, Ranu Jung
https://pubmed.ncbi.nlm.nih.gov/18566941/Swiss Paraplegic Research, Nottwil
Lead Sponsor